Abstract

BackgroundInterventional radiology includes a range of minimally invasive image-guided diagnostic and therapeutic procedures that have become routine clinical practice. Each procedure involves a percutaneous needle insertion, often guided using computed tomography (CT) because of its availability and usability. However, procedures remain complicated, in particular when an obstacle must be avoided, meaning that an oblique trajectory is required. Navigation systems track the operator’s instruments, meaning the position and progression of the instruments are visualised in real time on the patient’s images. A novel electromagnetic navigation system for CT-guided interventional procedures (IMACTIS-CT®) has been developed, and a previous clinical trial demonstrated improved needle placement accuracy in navigation-assisted procedures. In the present trial, we are evaluating the clinical benefit of the navigation system during the needle insertion step of CT-guided procedures in the thoraco-abdominal region.Methods/designThis study is designed as an open, multicentre, prospective, randomised, controlled interventional clinical trial and is structured as a standard two-arm, parallel-design, individually randomised trial. A maximum of 500 patients will be enrolled. In the experimental arm (navigation system), the procedures are carried out using navigation assistance, and in the active comparator arm (CT), the procedures are carried out with conventional CT guidance. The randomisation is stratified by centre and by the expected difficulty of the procedure. The primary outcome of the trial is a combined criterion to assess the safety (number of serious adverse events), efficacy (number of targets reached) and performance (number of control scans acquired) of navigation-assisted, CT-guided procedures as evaluated by a blinded radiologist and confirmed by an expert committee in case of discordance. The secondary outcomes are (1) the duration of the procedure, (2) the satisfaction of the operator and (3) the irradiation dose delivered, with (4) subgroup analysis according to the expected difficulty of the procedure, as well as an evaluation of (5) the usability of the device.DiscussionThis trial addresses the lack of published high-level evidence studies in which navigation-assisted CT-guided interventional procedures are evaluated. This trial is important because it addresses the problems associated with conventional CT guidance and is particularly relevant because the number of interventional radiology procedures carried out in routine clinical practice is increasing.Trial registrationClinicalTrials.gov identifier: NCT01896219. Registered on 5 July 2013.

Highlights

  • Interventional radiology includes a range of minimally invasive image-guided diagnostic and therapeutic procedures that have become routine clinical practice

  • The secondary outcomes are (1) the duration of the procedure, (2) the satisfaction of the operator and (3) the irradiation dose delivered, with (4) subgroup analysis according to the expected difficulty of the procedure, as well as an evaluation of (5) the usability of the device. This trial addresses the lack of published high-level evidence studies in which navigation-assisted computed tomography (CT)-guided interventional procedures are evaluated. This trial is important because it addresses the problems associated with conventional CT guidance and is relevant because the number of interventional radiology procedures carried out in routine clinical practice is increasing

  • This paper describes an open, multicentre, prospective, randomised, controlled clinical trial that has been designed to evaluate the clinical benefit, in terms of safety, efficacy and performance, of using the IMACTIS-CT® system for navigation-assisted CT guidance compared with conventional CT guidance during interventional radiological procedures in the thoraco-abdominal region

Read more

Summary

Discussion

Navigation assistance systems have demonstrated their value in the fields of orthopaedics, urology and neurosurgery. Training is provided for the participating radiologists and is obligatory before authorisation is granted to carry out a navigated procedure on a patient enrolled in the trial Another limitation is that the assignment to the experimental or comparator arm is open label for the radiologist. Ethics approval and consent to participate This trial is registered in the ClinicalTrials.gov database (NCT01896219) and was approved by the French Health Authority (Agence Nationale de Sécurité des Médicaments et des Produits de Santé, registered 19 June 2013 under ANSM reference number 2013-A00539-36) and the relevant ethics committee (Comité de Protection des Personnes, Sud-Est V, France, 12 June 2013, CPP reference number 13-CHUG-22) Both central ethics committees have approved this study for all eight centres involved.

Background
Methods/design
Methods
Findings
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call